eltrombopag

This medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (who have not responded to other medicines) and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (who have not responded to other medicines) and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after previous treatment with other methods) and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: ELPEN Pharmaceutical Co. Inc. S.A. Krka d.d., Novo mesto TAD Pharma GmbH

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after failure of other methods) and in adults with a low platelet count caused by hepatitis C virus infection.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: ELPEN Pharmaceutical Co. Inc. S.A. Krka d.d., Novo mesto TAD Pharma GmbH

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after failure of other methods) and in adults with hepatitis C who have experienced a low platelet count during interferon treatment.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: ELPEN Pharmaceutical Co. Inc. S.A. Krka d.d., Novo mesto TAD Pharma GmbH

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (ITP) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (ITP) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

This medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (ITP) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

The medicine is used to increase the number of platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (who have not responded to other medicines) and in adults with a low platelet count due to hepatitis C virus infection.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in patients for whom other medicines have not worked) and in adults with hepatitis C virus infection who have experienced difficulties due to adverse effects during interferon treatment.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of blood platelets. It is used to treat immune thrombocytopenia in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of platelets. It is intended for the treatment of immune thrombocytopenia (in patients for whom other medicines have not worked) and in adults with hepatitis C virus infection who have a low platelet count that makes antiviral treatment difficult.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have experienced difficulties due to adverse effects during interferon treatment.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with hepatitis C who have experienced a low platelet count during interferon treatment.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (when other medicines have not worked) and in adults with hepatitis C virus infection who have experienced difficulties due to adverse effects during interferon treatment.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with hepatitis C who have experienced a low platelet count during interferon treatment.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with a low platelet count caused by hepatitis C virus infection.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to increase the number of blood platelets. It is prescribed for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with a low platelet count due to hepatitis C virus infection.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (who have not responded to other medicines) and in adults with hepatitis C virus who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with a low platelet count due to hepatitis C virus infection.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (in patients for whom other medicines have not worked) and in adults with hepatitis C virus infection who have difficulties due to a low platelet count during interferon treatment.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Centrafarm Services B.V.

The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (primary) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Centrafarm Services B.V.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (primary) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Centrafarm Services B.V.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (who have not responded to other medicines) and in adults with hepatitis C virus infection who have a low platelet count that makes antiviral treatment difficult.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Coripharma ehf.

The medicine is used to increase the number of blood platelets. It is used to treat immune thrombocytopenia in individuals over 1 year of age (when other medicines have not worked) and in adults with hepatitis C virus infection who have experienced platelet problems during interferon treatment.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Coripharma ehf.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (when other medicines have not worked) and in adults with hepatitis C who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Coripharma ehf.

It is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after the failure of other medications) and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Genepharm S.A.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in people for whom other medicines have not worked) and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Genepharm S.A.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Genepharm S.A.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Genepharm S.A.

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (when other medicines have not worked) and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to increase the number of platelets. It is intended for the treatment of immune thrombocytopenia (in people for whom other medicines have not worked) and in adults with hepatitis C virus infection who have a low platelet count.

Form: tablets, film-coated

ATC: B02BX05

Manufacturer: Synthon B.V., Synthon Hispania S.L.